,i #aahth ,,congress #ast ,session ,h4 ,r4 #cfhd ,,in ,,the ,,house ,,of ,,representatives ,may #be1 #bjbc ,mr4 ,crenshaw 7for himself1 ,mr4 ,luttrell1 ,mr4 ,bergman1 ,ms4 ,mace1 ,mr4 ,gaetz1 ,ms4 ,ocasio-,cortez1 ,mr4 ,moskowitz1 ,mr4 ,zinke1 ,ms4 ,lee of ,florida1 ,mr4 ,correa1 and ,mr4 ,van ,orden7 introduced the following bill2 which was referred to the ,committee on ,armed ,services ,a ,,bill ,to direct the ,secretary of ,defense to establish a grant program for using psychedelic substances to treat certain conditions1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,douglas ,mike ,day ,psychedelic ,therapy to ,save ,lives ,act of #bjbc4 #b4 ,grant program of the ,department of ,defense to study treatment of certain conditions using certain psychedelic substances 7a7 ,establishment ,not later than #ij days after the date of enactment of this ,act1 the ,secretary of ,defense shall award grants to eligible entities to conduct research on the treatment of members of the ,armed ,forces serving on active duty with a covered condition using covered psychedelic substances4 ,not later than #fj days after the date of the enactment of this ,act1 the ,secretary shall designate a lead administrator to carry out the grant program under this section4 7b7 ,eligible entities ,the ,secretary may award a grant under this section to any of the following3 7#a7 ,a department or agency of the ,federal ,government or a ,state government4 7#b7 ,an academic institution4 7#c7 ,a nonprofit entity4 7c7 ,use of grant funds ,a recipient of a grant awarded under this section may use the grant to-- 7#a7 conduct one or more phase two clinical trials for the treatment of covered conditions that-- 7,a7 include members of the ,armed ,forces serving on active duty as participants in the clinical trial2 and 7,b7 use individual or group therapy assisted by covered psychedelic substances2 or 7#b7 train practitioners to provide treatment to members of the ,armed ,forces serving on active duty for covered conditions using covered psychedelic substances4 7d7 ,participation in clinical trials ,the ,secretary shall authorize any member of the ,armed ,forces diagnosed with a covered condition to participate in a clinical trial that is conducted using a grant awarded under this section or funds provided under subsection 7e7 and is authorized pursuant to section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee71 without regard to-- 7#a7 whether the clinical trial involves a substance included in the schedule under section #bjb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab72 or 7#b7 section #iab;a of title #aj1 ,united ,states ,code 7article #aab;a of the ,uniform ,code of ,military ,justice74 7e7 ,additional authority ,in addition to awarding grants under this section1 the ,secretary shall provide funds for a clinical research trial using covered psychedelic substances that is authorized pursuant to section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 and includes members of the ,armed ,forces as participants in the trial4 7f7 ,report required ,not later than #ahj days after the date of the enactment of this ,act1 and every #ahj days thereafter1 the ,secretary shall submit to the ,committees on ,armed ,services of the ,house of ,representatives and the ,senate a report on grants awarded under this section1 including the following3 7#a7 ,identification of clinics designated to host activities under such a grant4 7#b7 ,a description of entities to whom the ,secretary has awarded such a grant4 7#c7 ,the number of members of the ,armed ,forces who participated in a clinical trial described in subsection 7d74 7#d7 ,information on the findings of such clinical trials4 7g7 ,authorization of appropriations ,there is authorized to be appropriated to the ,secretary to carry out this section #ae1jjj1jjj for each of fiscal years #bjbd through #bjbh4 7h7 ,definitions ,in this section3 7#a7 ,the term covered condition means any of the following3 7,a7 ,post-traumatic stress4 7,b7 ,traumatic brain injury4 7,c7 ,chronic traumatic encephalopathy 7#b7 ,the term covered psychedelic substances means any of the following3 7,a7 #c1d-,methylenedioxy-methamphetamine 7commonly known as ,,mdma74 7,b7 ,psilocybin4 7,c7 ,ibogaine4 7,d7 #e-,methoxy-,n1,n-dimethyltryptamine 7commonly known as #e-,me,o-,,dmt74 7#c7 ,the term ,state has the meaning given such term in section #ija of title #cb1 ,united ,states ,code4